ARCUTIS BIOTHERAPEUTICS INC's ticker is ARQT and the CUSIP is 03969K108. A total of 102 filers reported holding ARCUTIS BIOTHERAPEUTICS INC in Q2 2021. The put-call ratio across all filers is 0.23 and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $676,255 | -50.2% | 127,277 | -10.7% | 0.00% | – |
| Q2 2023 | $1,356,809 | -71.8% | 142,599 | -67.5% | 0.00% | -100.0% |
| Q1 2023 | $4,819,085 | +87807.4% | 438,115 | +18.3% | 0.00% | 0.0% |
| Q4 2022 | $5,482 | -99.9% | 370,490 | +18.0% | 0.00% | 0.0% |
| Q3 2022 | $5,999,000 | -10.0% | 313,943 | +0.4% | 0.00% | 0.0% |
| Q2 2022 | $6,664,000 | +52.2% | 312,608 | +37.5% | 0.00% | +100.0% |
| Q1 2022 | $4,378,000 | +70.4% | 227,383 | +83.5% | 0.00% | 0.0% |
| Q4 2021 | $2,569,000 | +35.6% | 123,906 | +56.1% | 0.00% | 0.0% |
| Q3 2021 | $1,894,000 | +48.3% | 79,395 | +69.7% | 0.00% | – |
| Q2 2021 | $1,277,000 | – | 46,779 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| FRAZIER MANAGEMENT LLC | 10,542,790 | $314,175,000 | 35.62% |
| Bain Capital Life Sciences Investors, LLC | 3,979,292 | $118,583,000 | 20.06% |
| Omega Fund Management, LLC | 844,680 | $25,171,000 | 10.42% |
| Vivo Capital, LLC | 1,686,527 | $50,259,000 | 4.55% |
| Orbimed Advisors | 4,673,850 | $139,281,000 | 2.34% |
| RA Capital Management | 1,165,184 | $34,722,000 | 1.10% |
| Polar Capital LLP | 375,000 | $11,175,000 | 0.12% |
| CAAS CAPITAL MANAGEMENT LP | 22,413 | $668,000 | 0.07% |
| FMR LLC | 5,713,343 | $170,258,000 | 0.02% |
| Laurion Capital Management LP | 50,000 | $1,490,000 | 0.02% |